Net profit of Ipca Laboratories rose 340.98% to Rs 299.07 crore in the quarter ended March 2026 as against Rs 67.82 crore during the previous quarter ended March 2025. Sales rose 6.31% to Rs 2388.48 crore in the quarter ended March 2026 as against Rs 2246.69 crore during the previous quarter ended March 2025.
For the full year,net profit rose 54.69% to Rs 1141.12 crore in the year ended March 2026 as against Rs 737.68 crore during the previous year ended March 2025. Sales rose 7.91% to Rs 9646.33 crore in the year ended March 2026 as against Rs 8939.59 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 2388.48 | 2246.69 | 6 | 9646.33 | 8939.59 | 8 |
| OPM % | 20.26 | 19.09 | - | 20.51 | 19.31 | - |
| PBDT | 557.41 | 433.17 | 29 | 2077.07 | 1734.01 | 20 |
| PBT | 450.27 | 333.05 | 35 | 1658.95 | 1336.19 | 24 |
| NP | 299.07 | 67.82 | 341 | 1141.12 | 737.68 | 55 |
Powered by Capital Market - Live News